Spinal Muscular Atrophy (SMA): The CHOP-INTEND Scale, HFMSE, and Post-Nusinersen Rehabilitation
In short
Modern disease-modifying therapies for SMA arrest motor neuron death; structured physiotherapy using CHOP-INTEND and HFMSE rebuilds anti-gravity functional movement.
In this guide (4 sections)
Molecular Genetics and Motor Neuron Degeneration in SMA
Spinal Muscular Atrophy (SMA) is an autosomal recessive neuromuscular disease caused by homozygous deletions or loss-of-function mutations in the SMN1 gene (Survival Motor Neuron 1) on chromosome 5q. The resulting deficiency of full-length SMN protein leads to progressive degeneration and irreversible apoptosis of alpha motor neurons in the anterior horn of the spinal cord and brainstem motor nuclei.
The phenotypic severity is inversely correlated with the copy number of the centromeric modifier gene, SMN2. Classically divided into Type 1 (Werdnig-Hoffmann, non-sitters), Type 2 (sitters, non-walkers), and Type 3 (Kugelberg-Welander, walkers), the disease course has been revolutionized by disease-modifying therapies (Nusinersen antisense oligonucleotides, Risdiplam, and Onasemnogene abeparvovec AAV9 gene therapy). However, surviving motor neurons require intensive, structured neurodevelopmental rehabilitation to translate molecular rescue into functional motor milestones.
Standardized Clinical Outcome Measures Matrix
| Clinical Assessment Tool | Target Patient Cohort | Scoring Protocol & Scale Range | Clinical Meaning & Milestone Target | |
|---|---|---|---|---|
| CHOP-INTEND Scale | Non-sitters / SMA Type 1 infants | 16 motor items testing head, trunk, and limb movement; 0 to 64 points | Score > 40 points reflects anti-gravity motor control; scores < 20 indicate severe respiratory weakness | |
| Hammersmith Functional Motor Scale (HFMSE) | Sitters and Walkers / SMA Types 2 and 3 | 33 items assessing rolling, sitting, crawling, kneeling, standing; 0 to 66 pts | A 3-point gain reflects meaningful clinical functional improvement post-gene therapy | |
| Revised Upper Limb Module (RULM) | Non-ambulatory children and adults | 20 activities testing distal hand and proximal arm reach; 0 to 37 points | Measures preserved hand function for power wheelchair driving and eating | |
| 6-Minute Walk Test (6MWT) | Ambulatory SMA Type 3 patients | Measures distance walked; tracks exertional muscle fatigue | Drop in velocity during final 2 minutes flags neuromuscular junction fatigue | |
| Peak Cough Flow (PCF) | All SMA patients >= 4 years old | Handheld peak flow meter connected to face mask | PCF < 160 L/min indicates critical inability to clear secretions during infection |
Standardized Post-Gene-Therapy Rehabilitation Protocols
- Anti-Gravity Suspension and Mobile Arm Supports: Utilize overhead elastic sling suspension systems or robotic mobile arm supports (e.g., SaeboMAS); offloading gravity enables weak SMA patients to independently feed themselves, operate tablets, and strengthen surviving motor units.
- Early Standing Frame Protocol for Bone Mineralization: Introduce supported standing in a prone or supine stander for at least 60 minutes daily, 5 days per week; weight-bearing stimulates femoral acetabular development, increases bone density, and delays progressive neuromuscular scoliosis.
- Proactive Mechanical Airway Clearance Integration: Prescribe Mechanical Insufflation-Exsufflation (CoughAssist) twice daily for routine lung expansion; weak intercostal muscles lead to bell-shaped chest deformities and micro-atelectasis that mandate daily mechanical stretching.
Frequently Asked Questions
How do new gene therapies help babies with Spinal Muscular Atrophy (SMA)?
New medications (like Spinraza and Zolgensma) fix the broken genetic recipe inside nerve cells, stopping the spinal cord nerves from dying off. While the medication saves the nerves, physiotherapy is essential to teach the baby's muscles how to move, sit, and roll.
What is the CHOP-INTEND test in SMA?
The CHOP-INTEND is a 64-point motor test developed at the Children's Hospital of Philadelphia. A physiotherapist gently observes an infant's head control, kicking, hand gripping, and rolling to measure how much strength they are gaining after treatment.
Why do children with SMA need a standing frame if they cannot walk?
Standing in a specialized supportive standing frame for an hour a day lets gravity push weight down through the child's hip bones and legs. This builds strong bones, prevents hip dislocations, keeps joints flexible, and helps breathing.
Related condition guides
Related recovery guides & articles
BookPhysio.in Editorial Team
The BookPhysio.in editorial team writes and maintains this content, checking it against reliable clinical sources. Content follows our medical review policy: general information only, and no page claims a clinical review until a named registered physiotherapist has signed it off.
Read our medical review policy